Rephonic
Artwork for RealPharma: Conversations

RealPharma: Conversations with Pharma Pathfinders

RealPharma
Artificial Intelligence
Pharmaceutical Industry
Biopharma
Oncology
Digital Marketing
Healthcare Marketing
Executive Presence
Job Market Trends
Biopharma Job Market
Venture Capital
Radiopharmaceuticals
Clinical Trials
Synthetic Data
Data Strategy
First-Party Data
Patient Advocacy
Patient Engagement
Healthcare
Drug Development
Digital Twins

For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medic... more

PublishesMonthlyEpisodes62Founded3 years ago
Number of ListenersCategories
Life SciencesHealth & FitnessMedicineScience

Listen to this Podcast

Artwork for RealPharma: Conversations

Latest Episodes

Bridging the Gap: Market Access From Three Sides of the Table - with Vidhya Segar

Real Pharma, hosted by Na-Ri Oh and Ian Wendt, with intern Amos Fung

Episode Summary

Health technology assessment is usually described as a system. Vidhya Segar descri... more

The Mold Blind Spot: Ariana Thacker on Building the First Scalable Model of Care for CIRS

Real Pharma, hosted by Na-Ri Oh and Ian Wendt

Episode Summary

Somewhere between one in four Americans carries a genetic profile that makes it hard to clear b... more

From Patient Involvement to Patient Leadership: A Conversation with Donna Cryer, JD

Real Pharma, hosted by Na-Ri Oh and Ian Wendt

Episode Summary

As AI moves deeper into drug development, from trial design to evidence generation, the more pressing q... more

When Healthcare Policy Incentives Backfire: 340B, Hospital Pricing, MFN, and Drug Affordability with Deborah Williams

Healthcare policies are often evaluated by what they are intended to accomplish. But what happens when the incentives created by tho... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Raising Health
Raising HealthAndreessen Horowitz, a16z Bio + Health
Hard Fork
Hard ForkThe New York Times
The a16z Show
The a16z ShowAndreessen Horowitz

Recent Guests

Vidhya Segar
Pharmacist and market access strategist with experience at Singapore's Agency for Care Effectiveness
Ipsen
Episode: Bridging the Gap: Market Access From Three Sides of the Table with Vidhya Segar
Ariana Thacker
Chemical engineer, former venture investor, and founder and CEO of MoldCo
MoldCo
Episode: Let’s Talk About Mold - with Ariana Thacker
Donna Cryer
Lawyer, patient advocate, FDA patient representative, and founder of the Global Liver Institute
Global Liver Institute
Episode: From Patient Involvement to Patient Leadership - Donna Cryer, JD and Chief Patient Officer
Deborah Williams
Health policy leader with deep expertise at the intersection of reimbursement, regulation, legislation, and market access
Episode: Good Intentions, Bad Outcomes: Rethinking Healthcare Policy with Deborah Williams
Kristiaan Rawlings
Executive Director at EPM Scientific
EPM Scientific
Episode: The New Biopharma Talent Market: AI, M&A, and a K-Shaped Recovery
Christopher Gregg
Professor of neurobiology and genomics researcher, co-founder of Storyline Health, Primordial AI and Uncharted Health
University of Utah / Storyline Health / Primordial AI / Uncharted Health
Episode: What Farmers Know About Cancer with Chris Gregg
Paul Farrell Jr.
Attorney from Huntington, WV, lead figure in the West Virginia opioid litigation
West Virginia litigation team
Episode: The Opioid Reckoning (Part 2): Paul Farrell Jr.
Paul Farrell
A native of Huntington, West Virginia, prominent mass tort litigator leading MDL 2804
Attorney at law
Episode: The Opioid Reckoning (Part 1): Paul Farrell Jr.
Josh Resnikoff
Founder and CEO of Sunstone Health
Sunstone Health
Episode: Ending The Diagnostic Odyssey with Josh Resnikoff

Hosts

Dr. Na-Ri Oh
Host of RealPharma; frequent presenter on policy, pricing, and market access topics with deep health policy background.
Ian Wendt
Co-host focused on biopharma commercialization, editorial direction, and industry storytelling.

Reviews

5.0 out of 5 stars from 23 ratings
  • Great Hosts, Great Topics

    RealPharma dives into timely, relavant topics that matter to anyone in pharma or biotech.

    Apple Podcasts
    5
    Nazpari1140
    Canadaa year ago
  • Great topics and expert insights

    The recipe for a worthwhile podcast is a great topic with expert insight and perspective facilitated by knowledgeable and savvy hosts. Na-Ri and Ian are biopharma commercial professionals who know what needs to be further explored and discussed. And they find the experts who can advance the understanding as well as what needs to develop, evolve, or improve.

    Apple Podcasts
    5
    Fhjghfjcjfhx
    United States2 years ago
  • Great topics for Pharma professionals

    Really interesting topics delivered through the lens of what is relevant for biopharma professionals. Keeps me up to date with what is going on in the industry.

    Apple Podcasts
    5
    Snarf2000
    United States3 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate practical, expert-led discussions that cut through hype.
Guests often span policy, biotech, and patient advocacy, offering diverse perspectives.
Hosts bring real-world biopharma experience, making complex topics approachable.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Bridging the Gap: Market Access From Three Sides of the Table with Vidhya Segar
Q: Can you compare ACE to NICE in England or to ICER in the US? Is ACE stricter than other bodies?
Segar considers ACE functionally similar rather than stricter. She says Singapore's distinctive feature is that HTA is closely connected to funding decisions, with guidelines requiring a funded drug's subsidy to go live within six months.
Bridging the Gap: Market Access From Three Sides of the Table with Vidhya Segar
Q: Can you explain what the day in the life looks like when you are a market access professional?
Segar says the role includes reimbursement dossier submissions, reimbursement strategy, patient access programs, and securing tenders so medicines are available nationally. The work varies by market, including when access planning needs to begin relative to regulatory approval.
Let’s Talk About Mold - with Ariana Thacker
Q: How does MoldCo provide clinically rigorous care at a lower price?
Thacker describes a virtual model that offers a DIY environmental test, the Shoemaker Lab Panel through LabCorp, and clinical care with medications and other guidance. She says virtual delivery and relatively low medication costs help keep care affordable, while full-time clinical staff, training, and regular quality reviews support care standards.
From Patient Involvement to Patient Leadership - Donna Cryer, JD and Chief Patient Officer
Q: What is your perspective as we think about this new tool and the trends towards higher utilization of these tools? Is that a net positive for the work that you're doing?
Cryer sees AI as a lasting and potentially valuable tool, including for improving trial analysis and surfacing community resources. She says patient data and perspectives must inform AI systems, and human judgment, relationships, and patient leadership remain essential for assessing outputs and identifying which problems matter.
Let’s Talk About Mold - with Ariana Thacker
Q: What systemic improvements or changes would help address mold-related illness?
Thacker recommends establishing a mold commission under HHS, adding environmental health screening questions to annual visits, and creating an ICD-10 code for mold-related inflammatory illness. She also calls for more research, funding, collaboration, and patient advocacy.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About RealPharma: Conversations

What is RealPharma: Conversations about and what kind of topics does it cover?

A data-informed look at biopharma, healthcare policy, and patient-centered innovation, with hosts who bring industry-grade insight to conversations about pricing, access, and the enabling tech shaping medicine. Episodes frequently center on policy mechanisms (PBMs, IRA, 340B), market dynamics in biopharma talent and CDMOs, and practitioner-focused stories from executives, investigators, and patient advocates. The show often teases practical implications for employers, providers, and regulators, while highlighting how AI, data, and authentic engagement can influence strategy and care delivery. A notable strength is pairing policy rigor with real-world business and scientific implications, making complex topics accessible to professionals see... more

Where can I find podcast stats for RealPharma: Conversations?

Rephonic provides a wide range of podcast stats for RealPharma: Conversations. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to RealPharma: Conversations and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does RealPharma: Conversations get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for RealPharma: Conversations, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for RealPharma: Conversations?

Rephonic provides comprehensive predictive audience data for RealPharma: Conversations, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does RealPharma: Conversations have?

To see how many followers or subscribers RealPharma: Conversations has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to RealPharma: Conversations?

These podcasts share a similar audience with RealPharma: Conversations:

1. Raising Health
2. The Readout Loud
3. Hard Fork
4. The a16z Show
5. BioCentury This Week

How many episodes of RealPharma: Conversations are there?

RealPharma: Conversations launched 3 years ago and published 62 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact RealPharma: Conversations?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for RealPharma: Conversations?

Rephonic pulls ratings and reviews for RealPharma: Conversations from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for RealPharma: Conversations?

Rephonic provides full transcripts for episodes of RealPharma: Conversations. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on RealPharma: Conversations?

Recent guests on RealPharma: Conversations include:

1. Vidhya Segar
2. Ariana Thacker
3. Donna Cryer
4. Deborah Williams
5. Kristiaan Rawlings
6. Christopher Gregg
7. Paul Farrell Jr.
8. Paul Farrell

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days